# Infective Endocarditis Prophylaxis

Use a two-step decision: identify patients at highest risk of adverse endocarditis outcomes, then determine whether the planned dental procedure manipulates gingiva, periapical tissue, or oral mucosa. Give one preprocedure antibiotic dose only when both conditions are met.

**Clinical question:** Which patients require antibiotic prophylaxis before dental procedures, and which single-dose regimen should be used?

Updated: 2026-08-21T01:53:42.707903+00:00

## What matters in practice
- Reserve dental antibiotic prophylaxis for patients with cardiac conditions conferring the highest risk of adverse outcome from viridans group streptococcal infective endocarditis; do not extend it to broad moderate-risk groups. [5][9][10]
- For an indicated dental procedure, give a single dose 30-60 minutes before the procedure: amoxicillin 2 g orally for adults. [5]
- Clindamycin is no longer recommended for dental infective endocarditis prophylaxis. [5]
- In high-risk patients, invasive dental procedures have a temporal association with infective endocarditis within 4 weeks, strongest after extraction and oral surgery; observational data associate prophylaxis with lower event rates. [8][24]

## Require both a high-risk cardiac condition and an at-risk dental procedure

Do not prescribe prophylaxis based on a dental visit alone.

The practical U.S. approach is intentionally narrow: antibiotic prophylaxis is reasonable only for patients with the highest-risk cardiac conditions when they undergo dental procedures involving manipulation of gingival tissue, the periapical region of teeth, or perforation of oral mucosa. This strategy prioritizes prevention of severe adverse outcomes while limiting unnecessary antibiotic exposure and resistance selection. [5][9][10]

The relevant high-risk group includes prior infective endocarditis; prosthetic cardiac valves or prosthetic material used for valve repair, including percutaneous valve procedures; unrepaired cyanotic congenital heart disease; repaired congenital heart disease with palliative shunts or conduits; and cardiac transplant recipients who develop valvulopathy. Confirm the exact operative and congenital history before issuing a dental clearance, particularly when the patient reports a “repaired valve” or “repaired congenital defect.” [24]

Do not infer a prophylaxis indication from mitral valve disease, a rhythm device, or an older history of broadly defined “moderate-risk” heart disease. U.S. and European guideline revisions restricted prophylaxis to those at highest risk because randomized evidence is absent, historical prophylaxis failure was substantial, and broad antibiotic use carries population and individual harms. [10][11][22]
- Before prescribing, document the cardiac indication in the chart: prior infective endocarditis, prosthetic valve/prosthetic valve-repair material, qualifying congenital heart disease, or transplant valvulopathy. [24]
- Ask the dentist whether the procedure will manipulate gingiva or periapical tissues or perforate oral mucosa; routine dental attendance is not itself an indication. [5][9]
- If either the patient-risk criterion or procedural criterion is absent, do not use antibiotic prophylaxis. [5][9][10]

*Decision framework for antibiotic prophylaxis before dental procedures. [5][9][24]*

| Decision point | Action |
| --- | --- |
| Patient has prior IE, prosthetic valve or valve-repair material, unrepaired cyanotic congenital heart disease, repaired disease with palliative shunt/conduit, or transplant valvulopathy | Proceed to procedure assessment. [24] |
| Patient lacks a qualifying highest-risk condition | Do not prescribe dental IE prophylaxis. [5][9][10] |
| Qualifying patient undergoes a procedure manipulating gingiva/periapical tissue or perforating oral mucosa | Give one prophylactic antibiotic dose 30-60 minutes before the procedure. [5][9] |
| Qualifying patient has a dental encounter without an at-risk procedure | Do not prescribe solely for the encounter. [5][9] |

## Use a single dose 30-60 minutes before an indicated dental procedure

Choose the regimen by oral access and beta-lactam allergy history.

For adults able to take oral medication, amoxicillin 2 g orally is the standard regimen, administered as a single dose 30-60 minutes before the dental procedure. The timing is part of the regimen: prescriptions should specify administration before—not after—the procedure. [5]

When oral medication cannot be taken, use ampicillin 2 g intramuscularly or intravenously, or cefazolin or ceftriaxone 1 g intramuscularly or intravenously, as a single preprocedure dose. [5]

For a patient with penicillin or ampicillin allergy who can take oral medication, select cephalexin 2 g, azithromycin 500 mg, clarithromycin 500 mg, or doxycycline 100 mg as a single dose. Avoid cephalexin, cefazolin, and ceftriaxone in patients with an anaphylactoid-type beta-lactam hypersensitivity; in that setting, use a non-cephalosporin oral alternative when oral therapy is feasible. [5]

For a penicillin- or ampicillin-allergic patient unable to take oral medication, cefazolin 1 g IM/IV or ceftriaxone 1 g IM/IV is listed only when the allergy is not an anaphylactoid-type beta-lactam reaction. Clindamycin should not be substituted: it is no longer recommended for dental prophylaxis. [5]
- Write the order as one dose, 30-60 minutes before the procedure; do not prescribe a postoperative course. [5]
- Verify whether the reported penicillin reaction was anaphylactoid before selecting a cephalosporin. [5]
- Use doxycycline, azithromycin, or clarithromycin rather than clindamycin for an oral non-beta-lactam option. [5]

*Adult single-dose antibiotic regimens for indicated dental infective endocarditis prophylaxis, administered 30-60 minutes before the procedure. [5]*

| Clinical situation | Adult regimen |
| --- | --- |
| Able to take oral medication | Amoxicillin 2 g orally. [5] |
| Unable to take oral medication | Ampicillin 2 g IM/IV, or cefazolin 1 g IM/IV, or ceftriaxone 1 g IM/IV. [5] |
| Penicillin/ampicillin allergy; oral regimen feasible | Cephalexin 2 g, azithromycin 500 mg, clarithromycin 500 mg, or doxycycline 100 mg orally. [5] |
| Penicillin/ampicillin allergy; unable to take oral medication | Cefazolin 1 g IM/IV or ceftriaxone 1 g IM/IV; avoid these cephalosporins with anaphylactoid beta-lactam hypersensitivity. [5] |
| Any scenario | Do not use clindamycin for dental prophylaxis. [5] |

## Do not extrapolate dental prophylaxis to routine nondental procedures

Procedure type matters as much as cardiac risk.

The prophylaxis recommendation addressed here is for at-risk dental procedures in patients at highest cardiac risk. Contemporary guidance recommends prophylaxis for high-risk patients undergoing at-risk dental procedures and does not currently recommend it routinely for other procedures. [22]

Earlier AHA guidance limited consideration of prophylaxis for respiratory tract procedures or procedures involving infected skin, skin structures, or musculoskeletal tissue to selected circumstances. That is not a rationale to administer antibiotics for routine nondental procedures in a high-risk cardiac patient. When an active infection is being instrumented, treat the infection according to its expected microbiology and procedure-specific standards rather than reflexively applying the dental regimen. [7]

For respiratory, gastrointestinal, genitourinary, dermatologic, or device-related procedures, separately establish whether antimicrobial therapy is indicated for treatment of an active infection or for standard surgical-site prophylaxis. Do not label that treatment as endocarditis prophylaxis unless a procedure-specific recommendation applies. [7][22]
- Do not use the amoxicillin dental regimen as a default for gastrointestinal or genitourinary procedures. [22]
- If operating through infected skin or musculoskeletal tissue, choose antimicrobial management based on the infected site and anticipated pathogen rather than a routine dental prophylaxis protocol. [7]

## Emphasize oral health and evaluate postprocedure fever as possible endocarditis

Prophylaxis reduces neither baseline risk nor the need for diagnostic vigilance.

Antibiotic prophylaxis does not eliminate infective endocarditis risk. In high-risk patients, invasive dental procedures were temporally associated with infective endocarditis during the subsequent 4 weeks; the association was particularly strong for dental extractions and oral surgical procedures. [8]

Observational U.S. data support a protective association for prophylaxis in high-risk patients, but the prevention evidence remains limited and randomized trials are lacking. This uncertainty supports strict adherence to the narrow eligibility criteria rather than expansion to lower-risk cardiac populations. [8][10][11][12][24]

After a dental procedure, unexplained fever, night chills, weakness, myalgia, arthralgia, lethargy, or malaise in a patient at risk for endocarditis should prompt clinical assessment rather than reassurance based on receipt of prophylaxis. Blood cultures and echocardiography are the essential diagnostic tests when infective endocarditis is suspected. [4][17][18]

When clinical suspicion exists, obtain blood cultures before empiric antimicrobial therapy when feasible, then use echocardiography to assess for cardiac involvement. Prior antibiotics can contribute to blood culture-negative endocarditis; a compatible illness after dental care should therefore not be dismissed because a single prophylaxis dose was administered. [17][18]
- For high-risk patients with systemic symptoms within 4 weeks after extraction or oral surgery, assess for infective endocarditis and obtain blood cultures before empiric treatment when feasible. [8][17][18]
- Use echocardiography with blood cultures as the core diagnostic evaluation for suspected infective endocarditis. [17][18]
- Do not interpret prophylaxis receipt as exclusion of infective endocarditis. [4][18]

## References
1. Endocarditis prevention: time for a review of NICE guidance — www.thelancet.com — https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00042-5/fulltext
2. Prevention of Bacterial Endocarditis — jamanetwork.com — https://jamanetwork.com/HttpHandlers/ArticlePdfHandler.ashx?journal=jama&articleId=416761&pdfFileName=jama_277_22_033.pdf
3. Risk of infective endocarditis in patients with mitral valve ... — www.cell.com — https://www.cell.com/heliyon/fulltext/S2405-8440(24)15924-5
4. Prevention of Bacterial Endocarditis | Circulation — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/01.cir.96.1.358
5. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000000969
6. Infective Endocarditis in Adults: Diagnosis, Antimicrobial ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/cir.0000000000000296
7. Prevention of Infective Endocarditis | Circulation — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/circulationaha.106.183095
8. Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2022.06.030
9. ACC/AHA 2008 Guideline Update on Valvular Heart Disease — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2008.05.008
10. Challenges in Infective Endocarditis — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2016.10.066
11. Increase in Oral Streptococcal Endocarditis Among Moderate-Risk Patients: Impact of Guideline Changes on Endocarditis Prevention — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacadv.2024.101266
12. Endocarditis, invasive dental procedures, and antibiotic ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/odi.14585
13. Prophylactic Antibiotics for Prevention of Infective ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/scd.70112
14. Assessment of the current knowledge about infective ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/idh.12676
15. Biofilm formation in cardiovascular infection and ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/mba2.70003
16. A paradigm shift in diagnosing infective endocarditis — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0732889326001999
17. Infective endocarditis — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1470211824050863
18. Infective Endocarditis - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/neuroscience/infective-endocarditis
19. Infective endocarditis in patients who have undergone transcatheter aortic valve implantation: a review — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1198743X20300549
20. New guidelines for preventing infective endocarditis — journals.lww.com — https://journals.lww.com/nursing/fulltext/2007/08000/new_guidelines_for_preventing_infective.13.aspx
21. Infective Endocarditis Among High-risk Individuals Before and ... — academic.oup.com — https://academic.oup.com/cid/article/75/7/1171/6522819
22. 2023 ESC Guidelines for the management of endocarditis — academic.oup.com — https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad193/7243107
23. Guidelines on the prevention, diagnosis, and treatment of ... — academic.oup.com — https://academic.oup.com/eurheartj/article/30/19/2369/493681?ijkey=de906aa818ac8fa1905ef734850f2676b8c6e68d&keytype2=tf_ipsecsha
24. Should my patient receive antibiotics before dental ... — www.ccjm.org — https://www.ccjm.org/content/90/8/465

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.